T1	Participants 82 116	WHO type I anovulation infertility
T2	Participants 749 762	women with HH
T3	Participants 835 883	35 HH women (aged 25-36 yr) attending our Center
T4	Participants 885 1010	Eighteen patients received 150 IU hMG-HP (150 IU FSH + 150 IU LH-like activity) and seventeen received 150IU r-hFSH/75IU rhLH
T5	Participants 1867 1875	HH women
